13 hours ago • PR Newswire
iRegene Therapeutics announced promising NouvNeu001 Phase I clinical data
13 hours ago • PR Newswire
iRegene Therapeutics announced promising NouvNeu001 Phase I clinical data15 hours ago • PR Newswire
Lilly to present new clinical data for Verzenio (abemaciclib) and multiple novel pipeline programs at the 2025 European Society for Medical Oncology (ESMO) Annual Meeting2025-10-11 • markets.financialcontent.com
Prilenia and Ferrer to Share New Data and Analyses of Pridopidine’s Impact on Huntington’s Disease at the Huntington Study Group (HSG) Congress2025-10-11 • massdevice.com
Pulse Biosciences shares strong first-in-human PFA data2025-10-11 • thepharmaletter.com
Biogen and Stoke add to zorevunersen data package in Dravet syndrome2025-10-11 • globenewswire.com
Biogen and Stoke Therapeutics Present New Data at the 54th Child Neurology Society (CNS) Annual Meeting that Support the Potential of Zorevunersen as a Disease-Modifying Medicine for Dravet Syndrome2025-10-11 • insights.citeline.com
Henlius’s Serplulimab Could Offer First Chemo-Free Adjuvant Option In Perioperative Gastric Cancer2025-10-10 • gurufocus.com
Cabaletta Bio (CABA) Reports Positive Initial Results from RESET-PV Trial2025-10-09 • PR Newswire
Vytala™ Announces New Clinical Data and IRB Approval for Seracal™2025-10-09 • PR Newswire
New Clinical Data for Vivace Therapeutics' Best-in-Class, Hippo Pathway-Targeting Therapy to be Presented in Oral Presentation at the European Society for Medical Oncology (ESMO) Congress 20252025-10-08 • PR Newswire
C-Ray Therapeutics (Shanghai) Co., Ltd. Presents Breakthrough Clinical Data of Novel Targeted Alpha Therapy 225Ac-PSMA-CY313 at EANM 20252025-10-08 • globenewswire.com
Lexeo Therapeutics Announces Progress in FDA Discussions for Accelerated Approval Pathway and Positive Interim Clinical Data for LX2006 in Friedreich Ataxia Cardiomyopathy2025-10-08 • proactiveinvestors.com
Percheron Therapeutics posts positive final data from Phase I cancer trial of HMBD-0022025-10-08 • globenewswire.com
New Data Presented on Givinostat for Treatment of Duchenne Muscular Dystrophy at 2025 World Muscle Society Congress2025-10-08 • investingnews.com
Dyne Therapeutics Announces Additional One-Year Clinical Data Demonstrating Functional Improvement from Phase 1/2 ACHIEVE Trial of Zeleciment Basivarsen for Myotonic Dystrophy Type 12025-10-07 • gurufocus.com
Arcus Biosciences Rcus Shares Positive Data On Casdatifan For Metastatic Rcc2025-10-07 • stocktitan.net
Arvinas Presents Late Breaking, Positive Phase 1 Clinical Data for ARV-102, a PROTAC LRRK2 Degrader, at the 2025 International Congress of Parkinson’s Disease and Movement Disorders®2025-10-07 • PR Newswire
Novel Cancer Platforms Converge as Clinical Data Reshapes Treatment Paradigms2025-10-03 • manilatimes.net
Dianthus Therapeutics Highlights Claseprubart Data Presentations Planned for 2025 AANEM Annual Meeting2025-10-03 • stocktitan.net
Acadia Pharmaceuticals Presents Clinical Data from Across Multiple Therapeutic Programs at the 2025 International Congress of Parkinson’s Disease and Movement Disorders®2025-10-03 • stocktitan.net
Alterity Therapeutics to Deliver Multiple Presentations at the 2025 International Congress of Parkinson’s Disease and Movement Disorders2025-10-03 • globenewswire.com
HUTCHMED Highlights Clinical Data to be Presented at the ESMO Congress 20252025-10-02 • stocktitan.net
Arvinas to Present Clinical Data for ARV-102, a PROTAC LRRK2 Degrader, at the 2025 International Congress of Parkinson’s Disease and Movement Disorders®2025-10-02 • dermatologytimes.com
MoonLake Shares Findings from Dual Phase 3 Trials of Sonelokimab2025-10-01 • businesswire.com
Endeavor BioMedicines Announces Publication of Positive Data from Phase 2a Trial in The Lancet Respiratory Medicine Evaluating taladegib (ENV-101) in Individuals with Idiopathic Pulmonary Fibrosis2025-10-01 • stocktitan.net
Vivos Therapeutics Releases Additional Clinical Data Showing Marked Improvement in Pediatric ADHD from Use of Vivos DNA Device2025-10-01 • clinicaltrialsarena.com
Pfizer’s obesity bet shows 14.1% weight loss in Phase IIb trial2025-10-01 • globenewswire.com
Metsera Reports Positive Phase 2b Results for First- and Best-in-Class Ultra-long Acting GLP-1 RA Candidate MET-097i, Enabling Rapid Transition into Phase 32025-10-01 • stocktitan.net
Cellectar Biosciences Presented Compelling Data in Oral Session and Panel Discussions at the American Association for Cancer Research Special Conference on Discovery and Innovation in Pediatric Cancer2025-10-01 • stocktitan.net
Anavex Life Sciences Announces Publication of Oral Blarcamesine Describing a New Class of Clinical Precision Medicine from Phase IIb/III Alzheimer’s Disease Trial3 hours ago • prnewswire.co.uk
The Bahamas Achieves Major Fiscal Progress, Strengthening its Position as a Stable and Sustainable Financial Partner5 hours ago • prnewswire.co.uk
Allergic Rhino-Conjunctivitis Market Poised for Significant Growth in the Coming 10 Years Amid Increasing Therapeutic Advancements | DelveInsight11 hours ago • fortuneindia.com
U.S. tariff hits Indian textile and apparel exporters; 50% drop in revenues, says survey11 hours ago • teslarati.com
xAI’s new facility will save Memphis 5 billion gallons of water annually11 hours ago • packaging-gateway.com
Amazon UAE introduces packaging recycling initiative across Dubai11 hours ago • hawaiinewsnow.com
10th LeaLea Charity Run proceeds to support Waikiki Aquarium11 hours ago • smallcaps.com.au
St George Mining’s Capital Raise for Araxá Project in Brazil Sees Big-Name Backing11 hours ago • marcamoney.com
Ekkaa Electronics raises ₹108 crore in Series A funding round11 hours ago • scmp.com
Hong Kong poised for greater role in Islamic finance, financial secretary says11 hours ago • cryptocurrencywire.com
Forward Industries, Inc. (NASDAQ: FORD) Extends Resale Registration Filing Amid Market Volatility, Reaffirms Long-Term Solana Strategy11 hours ago • defensewirenews.com
Datavault AI (NASDAQ: DVLT) Files Federal Lawsuit Alleging Market Manipulation, Defamation and Securities Fraud11 hours ago • missionir.com
Strawberry Fields REIT, Inc. (NYSE AMERICAN: STRW) to Present at LD Micro’s 19th Annual Main Event on Oct. 211 hour ago • EIN Presswire
Phillips & Associates Attorneys Join Multi-Million Dollar Advocates Forum®1 hour ago • EIN Presswire
IDX Dynamic Fixed Income ETF (DYFI) Surpasses $50 Million in Assets1 hour ago • EIN Presswire
BNT Impact Windows and Doors Helps South Florida Homeowners Access Up to $10000 in State Grants for Hurricane Protection11 hours ago • moneycontrol.com
Jupiter Life Line in Rs 1,400-crore expansion push in Maharashtra, to double capacity by 202911 hours ago • indiantextilemagazine.in
Major Amendments to PLI Scheme, A Big Boost for MMF and Technical Textile Sectors11 hours ago • marcamoney.com
Ekkaa Electronics raises ₹108 crore in Series A funding round5 minutes ago • EIN Presswire
Amyloidosis Therapeutics Market Size to Hit US$ 8.20 Bn by 2032, Reports Persistence Market Research5 hours ago • EIN Presswire
Medical Fiber Optics Market Set to Boom to US$2.3 Billion by 2032 – Persistence Market Research5 hours ago • EIN Presswire
Vaginal Specula Market to Reach US$1.4 Billion by 2032, Growing at 3.9% CAGR – Persistence Market ResearchStay ahead with real-time headlines from top sources, categorized by sector and country.